Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care (Q38184384)

30 August 2017

title

Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care (English)

1 reference

carcinoma of unknown primary

30 August 2017

main subject

1 reference

John D Hainsworth

1 reference

30 August 2017

F Anthony Greco

1 reference

30 August 2017

language of work or name

1 reference

1 February 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

464

1 reference

30 August 2017

1 reference

30 August 2017

page(s)

393-402

1 reference

Switching benchmarks in cancer of unknown primary: from autopsy to microarray

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Treatment for patients with unknown primary carcinoma and unfavorable prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Multiclass cancer diagnosis using tumor gene expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Elucidation of a protein signature discriminating six common types of adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Feature selection and molecular classification of cancer using genetic programming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Validation and Reproducibility of a Microarray-Based Gene Expression Test for Tumor Identification in Formalin-Fixed, Paraffin-Embedded Specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

A second-generation microRNA-based assay for diagnosing tumor tissue origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Blinded comparator study of immunohistochemical analysis versus a 92-gene cancer classifier in the diagnosis of the primary site in metastatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Use of tumour marker immunoreactivity to identify primary site of metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Pathologic evaluation of unknown primary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Determining tissue of origin for metastatic cancers: meta-analysis and literature review of immunohistochemistry performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Diagnostic and therapeutic management of cancer of an unknown primary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Diagnostic strategies for unknown primary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

A multicenter study directly comparing the diagnostic accuracy of gene expression profiling and immunohistochemistry for primary site identification in metastatic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Comparison of histopathological and gene expression-based typing of cancer of unknown primary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Molecular profiling for druggable genetic abnormalities in carcinoma of unknown primary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

MET mutations in cancers of unknown primary origin (CUPs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-014-1545-2

Metastatic and histologic presentations in unknown primary cancer

21 January 2018

1 reference

12 December 2020

Molecular classification of human carcinomas by use of gene expression signatures.

1 reference

12 December 2020

RNA expression analysis of formalin-fixed paraffin-embedded tumors

1 reference

12 December 2020

Multisite validation study to determine performance characteristics of a 92-gene molecular cancer classifier

1 reference

12 December 2020

Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site

1 reference

12 December 2020

Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology

1 reference

12 December 2020

Overexpression of Her-2 in patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary site

1 reference

12 December 2020

Immunohistologic evaluation of metastatic carcinomas of unknown origin: an algorithmic approach.

1 reference

12 December 2020

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset.

1 reference

12 December 2020

Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002).

1 reference

12 December 2020

Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay

1 reference

12 December 2020

Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma

1 reference

12 December 2020

Multicenter validation of a 1,550-gene expression profile for identification of tumor tissue of origin

1 reference

12 December 2020

Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors.

1 reference

12 December 2020

Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary

1 reference

12 December 2020

10.1007/S00428-014-1545-2

Identifiers

DOI

1 reference

30 August 2017

1 reference